Biopharm R&D Corporation Limited – Trademark Portfolio
Entity Type: 03
Biopharm R&D Corporation Limited holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include BIOPHARM. The owner is based in Herndon, VA.
1162 Millwood Pond Drive
Herndon, VA 20170
Showing of trademarks Trademarks
Trademark Classifications
Biopharm R&D Corporation Limited's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does Biopharm R&D Corporation Limited have?
Biopharm R&D Corporation Limited has 5 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 abandoned, 2 cancelled.
What trademark classes does Biopharm R&D Corporation Limited file in?
Biopharm R&D Corporation Limited files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning), Class 1 (Chemicals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Biopharm R&D Corporation Limited's most well-known trademarks?
Biopharm R&D Corporation Limited's registered trademark portfolio includes well-known marks such as BIOPHARM. These are among 1 currently registered trademark in the portfolio.
What is Biopharm R&D Corporation Limited's trademark registration success rate?
Biopharm R&D Corporation Limited has a 20% trademark registration rate, with 1 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.